default_top_notch
default_news_top
default_news_ad1
default_nd_ad1

Regulator to nix approval for Lou Gehrig's drug Yoos Neurosolution

Lee Hye-seon  Published 2019.01.07  12:46  Updated 2019.01.07 12:46

공유
default_news_ad2

The Korean drug regulator is likely to nullify approval for Yoos Neurosolution (ingredient: ursodeoxycholic acid), a medicine that inhibits the progression of Lou Gehrig’s disease.

However, the canceling of the license will have no impact on patients, as an alternative treatment is available, and no patient is taking the drug, observers said.

Lou Gehrig’s disease treatment Yoos Neurosolution by Yoos Pharm Korea

According to the minutes of the Ministry of Food and Drug Safety’s central pharmaceutical affairs advisory committee, the panelists advised the ministry nullify the nod for Yoos Neurosolution.

In 2009, the government approved the drug on the condition that the drug manufacturer conducts a phase-3 trial. The treatment is made from a high-content liquid agent of ursodeoxycholic acid, which is well known as the main ingredient of hepatic protector Ursa.

Drugmaker Yoos Pharm Korea said its Lou Gehrig's treatment is anti-apoptotic and neuroprotective. Without altering the molecular structure of ursodeoxycholic acid, the drug prevents progression of muscle regeneration and improves symptoms by inhibiting apoptosis, the company said.

Although ursodeoxycholic acid was widely well known, physicians rarely prescribed Yoos Neurosolution because it cost as high as 19 million won ($17,053) a year.

Yoos Pharm applied for a phase-3 trial in 2014 but has failed to conduct the study to date.

The ministry asked the pharmaceutical firm to submit the result of the phase-3 trial by June 23, 2018. However, the company requested to extend the deadline until June 23, 2023, without proceeding with the trial.

The members of the central pharmaceutical affairs advisory committee did not accept the company’s request.

Lou Gehrig's disease destroys motor neurons only. Its official name is amyotrophic lateral sclerosis (ALS).

Drugs that can be used to treat Lou Gehrig's disease include Rilutek Tab., Uritek Tab., Radicut Inj., and Nuedexta.

lhs@docdocdoc.co.kr

<© KBR , All rights reserved.>
default_news_ad5
default_news_bottom
default_nd_ad4
default_bottom
#top
default_bottom_notch